• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β 信号通路在胃肠道癌症中的作用。

The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers.

机构信息

Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, Osaka 5458585, Japan.

出版信息

Biomolecules. 2023 Oct 19;13(10):1551. doi: 10.3390/biom13101551.

DOI:10.3390/biom13101551
PMID:37892233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10605301/
Abstract

Transforming growth factor-β (TGF-β) has attracted attention as a tumor suppressor because of its potent growth-suppressive effect on epithelial cells. Dysregulation of the TGF-β signaling pathway is considered to be one of the key factors in carcinogenesis, and genetic alterations affecting TGF-β signaling are extraordinarily common in cancers of the gastrointestinal system, such as hereditary nonpolyposis colon cancer and pancreatic cancer. Accumulating evidence suggests that TGF-β is produced from various types of cells in the tumor microenvironment and mediates extracellular matrix deposition, tumor angiogenesis, the formation of CAFs, and suppression of the anti-tumor immune reaction. It is also being considered as a factor that promotes the malignant transformation of cancer, particularly the invasion and metastasis of cancer cells, including epithelial-mesenchymal transition. Therefore, elucidating the role of TGF-β signaling in carcinogenesis, cancer invasion, and metastasis will provide novel basic insight for diagnosis and prognosis and the development of new molecularly targeted therapies for gastrointestinal cancers. In this review, we outline an overview of the complex mechanisms and functions of TGF-β signaling. Furthermore, we discuss the therapeutic potentials of targeting the TGF-β signaling pathway for gastrointestinal cancer treatment and discuss the remaining challenges and future perspectives on targeting this pathway.

摘要

转化生长因子-β(TGF-β)因其对上皮细胞具有强烈的生长抑制作用而被视为肿瘤抑制因子。TGF-β 信号通路的失调被认为是致癌的关键因素之一,影响 TGF-β 信号的遗传改变在胃肠道癌症中非常常见,如遗传性非息肉病性结肠癌和胰腺癌。越来越多的证据表明,TGF-β 由肿瘤微环境中的各种细胞产生,并介导细胞外基质沉积、肿瘤血管生成、CAFs 的形成以及抑制抗肿瘤免疫反应。它也被认为是促进癌症恶性转化的因素,特别是癌细胞的侵袭和转移,包括上皮-间充质转化。因此,阐明 TGF-β 信号在致癌作用、癌症侵袭和转移中的作用将为胃肠道癌症的诊断和预后提供新的基础见解,并为开发新的分子靶向治疗方法提供基础。在这篇综述中,我们概述了 TGF-β 信号的复杂机制和功能。此外,我们讨论了靶向 TGF-β 信号通路治疗胃肠道癌症的治疗潜力,并讨论了针对该通路的剩余挑战和未来展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34df/10605301/d36f44403fd1/biomolecules-13-01551-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34df/10605301/1f0859803402/biomolecules-13-01551-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34df/10605301/c8a760564fbb/biomolecules-13-01551-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34df/10605301/d36f44403fd1/biomolecules-13-01551-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34df/10605301/1f0859803402/biomolecules-13-01551-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34df/10605301/c8a760564fbb/biomolecules-13-01551-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34df/10605301/d36f44403fd1/biomolecules-13-01551-g003.jpg

相似文献

1
The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers.转化生长因子-β 信号通路在胃肠道癌症中的作用。
Biomolecules. 2023 Oct 19;13(10):1551. doi: 10.3390/biom13101551.
2
Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy.转化生长因子-β信号通路:肿瘤发生与癌症治疗靶点
J Cell Physiol. 2019 Aug;234(8):12173-12187. doi: 10.1002/jcp.27955. Epub 2018 Dec 7.
3
Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment.转化生长因子-β在胃肠道和肝脏肿瘤微环境中的作用。
Gastroenterology. 2011 Oct;141(4):1167-78. doi: 10.1053/j.gastro.2011.07.048. Epub 2011 Aug 11.
4
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.TGF-β 介导电报上皮-间充质转化与癌症转移。
Int J Mol Sci. 2019 Jun 5;20(11):2767. doi: 10.3390/ijms20112767.
5
TGF-beta signaling and its targeted therapy in gastrointestinal cancers.转化生长因子-β信号传导及其在胃肠道癌症中的靶向治疗
Discov Med. 2018 Sep;26(142):103-112.
6
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.转化生长因子-β信号传导的双重性质:肿瘤抑制因子与肿瘤促进因子
Curr Opin Oncol. 2005 Jan;17(1):49-54. doi: 10.1097/01.cco.0000143682.45316.ae.
7
Targeting TGFβ signal transduction for cancer therapy.针对 TGFβ 信号转导的癌症治疗。
Signal Transduct Target Ther. 2021 Jan 8;6(1):8. doi: 10.1038/s41392-020-00436-9.
8
TGFβ Signaling in the Tumor Microenvironment.TGFβ 信号在肿瘤微环境中的作用。
Adv Exp Med Biol. 2021;1270:89-105. doi: 10.1007/978-3-030-47189-7_6.
9
Molecular mechanism of TGF-β signaling pathway in colon carcinogenesis and status of curcumin as chemopreventive strategy.转化生长因子-β信号通路在结肠癌发生中的分子机制及姜黄素作为化学预防策略的现状
Tumour Biol. 2014 Aug;35(8):7295-305. doi: 10.1007/s13277-014-1840-1. Epub 2014 Mar 26.
10
TGF-β Signaling in Cancer.癌症中的转化生长因子-β信号传导
J Cell Biochem. 2016 Jun;117(6):1279-87. doi: 10.1002/jcb.25496. Epub 2016 Feb 11.

引用本文的文献

1
Development and validation of a novel risk stratification signature derived from migrasome and tumor microenvironment-related genes for molecular subtyping and improving clinical outcomes in head and neck squamous cell carcinoma.基于迁移小体和肿瘤微环境相关基因的新型风险分层特征的开发与验证,用于头颈部鳞状细胞癌的分子分型及改善临床结局
Ann Med. 2025 Dec;57(1):2558121. doi: 10.1080/07853890.2025.2558121. Epub 2025 Sep 9.
2
Role of ETS2 gene in inflammatory bowel disease: A narrative review.ETS2基因在炎症性肠病中的作用:一篇叙述性综述。
Medicine (Baltimore). 2025 Sep 5;104(36):e44234. doi: 10.1097/MD.0000000000044234.
3

本文引用的文献

1
A novel long non-coding RNA XLOC_004787, is associated with migration and promotes cancer cell proliferation by downregulating mir-203a-3p in gastric cancer.一种新型长非编码 RNA XLOC_004787 与迁移有关,并通过下调胃癌中的 mir-203a-3p 促进癌细胞增殖。
BMC Gastroenterol. 2023 Aug 12;23(1):280. doi: 10.1186/s12876-023-02912-2.
2
High miR-200c expression is associated with suppressed epithelial-mesenchymal transition, TGF-β signaling and better survival despite enhanced cell proliferation in gastric cancer patients.尽管胃癌患者的细胞增殖增强,但高表达的miR-200c与上皮-间质转化的抑制、TGF-β信号传导以及更好的生存率相关。
Am J Cancer Res. 2023 Jul 15;13(7):3027-3040. eCollection 2023.
3
Transforming Growth Factor-β Pathway: Biological Functions and Therapeutic Targets.
转化生长因子-β信号通路:生物学功能与治疗靶点
MedComm (2020). 2025 Jun 27;6(7):e70278. doi: 10.1002/mco2.70278. eCollection 2025 Jul.
4
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.与埃及丙型肝炎病毒肝硬化患者直接作用抗病毒治疗前后肝癌发生风险相关的外周免疫特征。
Virol J. 2024 Nov 15;21(1):293. doi: 10.1186/s12985-024-02551-3.
5
Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer.建立一种新的糖尿病相关代谢特征以预测胰腺癌的预后和免疫格局。
Carcinogenesis. 2025 Apr 3;46(2). doi: 10.1093/carcin/bgae072.
6
Molecular Mechanism for Malignant Progression of Gastric Cancer Within the Tumor Microenvironment.肿瘤微环境中胃癌恶性进展的分子机制。
Int J Mol Sci. 2024 Oct 31;25(21):11735. doi: 10.3390/ijms252111735.
7
Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases.生长因子及其在遗传性神经退行性疾病治疗中的应用。
Biomedicines. 2024 Aug 20;12(8):1906. doi: 10.3390/biomedicines12081906.
8
Editorial: Clinical risk assessment and intervention of gastrointestinal tumors driven by big-data.社论:大数据驱动的胃肠道肿瘤临床风险评估与干预
Front Med (Lausanne). 2024 Feb 27;11:1379762. doi: 10.3389/fmed.2024.1379762. eCollection 2024.
9
Molecular Insight into Gastric Cancer Invasion-Current Status and Future Directions.胃癌侵袭的分子洞察——现状与未来方向
Cancers (Basel). 2023 Dec 21;16(1):54. doi: 10.3390/cancers16010054.
Small extracellular vesicle TGF-β in cancer progression and immune evasion.
小细胞外囊泡 TGF-β 在癌症进展和免疫逃逸中的作用。
Cancer Gene Ther. 2023 Oct;30(10):1309-1322. doi: 10.1038/s41417-023-00638-7. Epub 2023 Jun 21.
4
Downregulated miR-495-3p in colorectal cancer targets TGFβR1, TGFβR2, SMAD4 and BUB1 genes and induces cell cycle arrest.结直肠癌中下调的miR-495-3p靶向TGFβR1、TGFβR2、SMAD4和BUB1基因并诱导细胞周期停滞。
Cancer Treat Res Commun. 2023;35:100702. doi: 10.1016/j.ctarc.2023.100702. Epub 2023 Apr 5.
5
miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2.miR-17-5p 通过下调 TGFβR2 来减缓肝细胞癌的进展。
Clin Transl Oncol. 2023 Oct;25(10):2960-2971. doi: 10.1007/s12094-023-03164-y. Epub 2023 Apr 6.
6
Correlation between SMADs and Colorectal Cancer Expression, Prognosis, and Immune Infiltrates.SMADs与结直肠癌的表达、预后及免疫浸润之间的相关性
Int J Anal Chem. 2023 Mar 8;2023:8414040. doi: 10.1155/2023/8414040. eCollection 2023.
7
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy.在接受检查点抑制剂联合放疗的胰腺癌患者中,预先存在的 TGF-β 特异性 T 细胞免疫预测生存。
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-006432.
8
Efficacy of therapies targeting TGF-β in solid tumors: a systematic review and meta-analysis of clinical trials.靶向 TGF-β 的疗法在实体瘤中的疗效:临床试验的系统评价和荟萃分析。
Immunotherapy. 2023 Mar;15(4):283-292. doi: 10.2217/imt-2022-0079. Epub 2023 Feb 15.
9
NamiRNA-enhancer network of miR-492 activates the NR2C1-TGF-β/Smad3 pathway to promote epithelial-mesenchymal transition of pancreatic cancer.miR-492 的 NamiRNA 增强子网络激活 NR2C1-TGF-β/Smad3 通路促进胰腺癌上皮间质转化。
Carcinogenesis. 2023 May 26;44(2):153-165. doi: 10.1093/carcin/bgac102.
10
Non-coding RNAs are correlated to TGF-β receptor type 2 in patients with colorectal cancer.非编码 RNA 与结直肠癌患者的 TGF-β 受体 2 相关。
J Gene Med. 2023 Mar;25(3):e3472. doi: 10.1002/jgm.3472. Epub 2023 Jan 11.